Literature DB >> 2655744

bcr rearrangement and C-abl gene expression in Ph1-positive hybrid acute leukemia with simultaneous proliferation of lymphoid and myeloid blasts.

M Okabe1, M Oita, Y Kunieda, J Matsuura, K Sakurada, S Matsushima, M Kakinuma, T Miyazaki.   

Abstract

bcr gene rearrangement and c-abl gene expression were analyzed in a patient with Philadelphia chromosome (Ph1)-positive hybrid acute leukemia with simultaneous proliferation of lymphoid and myeloid blasts. These data were compared with those from a patient with chronic myelogenous leukemia (CML) in mixed crisis. The leukemic cells of both patients showed immuno-phenotypic profiles such as non-T, non-B common ALL with some MPO-positive leukemic cells and rearranged JH genes. On analysis of molecular events associated with the Ph1 chromosome, the leukemic cells of a patient with CML in mixed crisis showed bcr rearrangement and an 8.5-kb bcr-abl chimeric mRNA, but those of a patient with Ph1-positive hybrid acute leukemia showed no 8.5-kb bcr-abl mRNA, as previously reported in a number of Ph1-positive acute lymphoblastic leukemia (ALL) cases. These results revealed that the molecular event found in Ph1-positive ALL is not only restricted to lymphoid lineage but may play an important role in the proliferation of the myeloid lineage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2655744     DOI: 10.1007/bf00320912

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

1.  Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

Authors:  A Hermans; N Heisterkamp; M von Linden; S van Baal; D Meijer; D van der Plas; L M Wiedemann; J Groffen; D Bootsma; G Grosveld
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

2.  Multiparameter studies in lymphoid leukemias.

Authors:  D Catovsky; S Pittman; M O'Brien; M Cherchi; C Costello; R Foa; E Pearce; A V Hoffbrand; G Janossy; K Ganeshaguru; M F Greaves
Journal:  Am J Clin Pathol       Date:  1979-10       Impact factor: 2.493

3.  Distinguishing the Philadelphia chromosome of acute lymphoblastic leukemia from its counterpart in chronic myelogenous leukemia.

Authors:  S Rodenhuis; L A Smets; R M Slater; H Behrendt; A J Veerman
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

4.  Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.

Authors:  S S Clark; J McLaughlin; W M Crist; R Champlin; O N Witte
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

5.  RFLP detected with a 5'-bcr-gene-sequence (HGM8 provisional no. D22S11).

Authors:  E Roschmann; G Assum; T Fink
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

6.  Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.

Authors:  K Stam; N Heisterkamp; G Grosveld; A de Klein; R S Verma; M Coleman; H Dosik; J Groffen
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

7.  The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.

Authors:  Y Ben-Neriah; G Q Daley; A M Mes-Masson; O N Witte; D Baltimore
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

8.  Philadelphia-positive chronic myelogenous leukemia with breakpoint 5' of the breakpoint cluster region but within the bcr gene.

Authors:  C R Bartram; U Bross-Bach; H Schmidt; H D Waller
Journal:  Blut       Date:  1987-12

9.  Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.

Authors:  S J Korsmeyer; A Arnold; A Bakhshi; J V Ravetch; U Siebenlist; P A Hieter; S O Sharrow; T W LeBien; J H Kersey; D G Poplack; P Leder; T A Waldmann
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  1 in total

1.  Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript.

Authors:  Y Kunieda; M Okabe; M Kurosawa; T Itaya; M Kakinuma; T Miyazaki
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.